International Immunology Advance Access originally published online on May 20, 2008
International Immunology 2008 20(7):937-947; doi:10.1093/intimm/dxn052
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I–
βTCR interaction and become IL-10-producing active regulatory cells
1 Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan
2 Department of Biology, Faculty of Science, Brawijaya University, Malang 65145, East-Java, Indonesia
3 Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan
4 Department of Cancer Vaccine
5 Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Tsu 514-8507, Japan
Correspondence to: H. Suzuki; E-mail: k46200a{at}nucc.cc.nagoya-u.ac.jp
CD8+CD122+ regulatory T cells (CD8+CD122+ Treg) are naturally occurring Treg that effectively suppress the proliferation and IFN-
production of both CD8+ and CD4+ target cells. This study investigated the molecular mechanisms of the recognition of target cells by CD8+CD122+ Treg using an in vitro culture system that reconstitutes the regulatory action of these cells. Naive CD8+CD122+ Treg co-cultured with pre-activated T cells became active Treg that produced IL-10 and suppressed IFN-
production from the target T cells. CD8+CD122+ Treg effectively suppressed the IFN-
production of the target cells of syngeneic mouse strains but not of allogeneic mouse strains with incompatible MHC. By using MHC-congeneic mouse strains, MHC-restricted suppression by CD8+CD122+ Treg was further confirmed. The blockade of cell surface molecules either on the Treg or on the target cells by specific blocking antibodies indicated that H-2K, H-2D,
βTCR and CD8 were involved in the regulatory action but I-A and Qa-1 were not. These results indicate that CD8+CD122+ Treg recognize already-activated T cells via the interaction of conventional MHC class I–
βTCR and become active regulatory cells that produce IL-10 and suppress the target cells.
Keywords: in vitro assay, mouse, suppression, Treg
* These authors contributed equally to this work.
Transmitting editor: K. Okumura
Received 4 March 2008, accepted 25 April 2008.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. R. Kiesel, Z. S. Buchwald, and R. Aurora Cross-Presentation by Osteoclasts Induces FoxP3 in CD8+ T Cells J. Immunol., May 1, 2009; 182(9): 5477 - 5487. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Siegmund, B. Ruckert, N. Ouaked, S. Burgler, A. Speiser, C. A. Akdis, and C. B. Schmidt-Weber Unique Phenotype of Human Tonsillar and In Vitro-Induced FOXP3+CD8+ T Cells J. Immunol., February 15, 2009; 182(4): 2124 - 2130. [Abstract] [Full Text] [PDF] |
||||
